Rockwell Medical (RMTI) Tax Provisions (2011 - 2016)
Rockwell Medical (RMTI) posted Tax Provisions of -$7.0 million for Q4 2016, down 1830.41% on a QoQ basis from $404527.0 in Q1 2016.
Rockwell Medical (RMTI) Tax Provisions (2011 - 2016) Analysis & Trends
Rockwell Medical's Tax Provisions history runs 3 years deep, the most recent figure standing at -$7.0 million for Q4 2016.
- Quarterly Tax Provisions changed N/A year-over-year to -$7.0 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was -$6.6 million (changed N/A YoY) and the FY2017 annual result came in at -$8.8 million, down 33.63% from the prior year.
- Tax Provisions was -$7.0 million for Q4 2016 at Rockwell Medical, down from $404527.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $404527.0 in Q1 2016 and bottomed at -$16.6 million in Q4 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 30.00 Mn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | -7.00 Mn |
| Mar 31, 2016 | 404,527.00 |
| Dec 31, 2013 | -16.58 Mn |
| Dec 31, 2011 | 47.00 |
| Sep 30, 2011 | 1,958.00 |